—

Axsome Therapeutics Inc (AXSM) — the peer cohort

As of 2026-11-19 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Axsome Therapeutics Inc ranks 7 of 7 in its cohort on the Closelooknet composite (36/100) — the cohort is led by Halozyme Therapeutics Inc at 72/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
AXSM Axsome Therapeutics Inc 36 13 23 18 warn 47.9%
HALO Halozyme Therapeutics Inc 72 66 94 52 info 30.6%
ONC BeOne Medicines AG 66 87 68 29 ok 5.9%
REGN Regeneron Pharmaceuticals Inc 66 91 73 47 watch 4.7%
ARGX.BR Argen-X 64 80 75 26 ok 7.2%
UCB.BR UCB SA 64 76 71 42 info 6%
ARGX argenx NV ADR 63 69 74 26 ok 12.2%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-19

Quick answers

Who are Axsome Therapeutics Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), BeOne Medicines AG (ONC), Regeneron Pharmaceuticals Inc (REGN), Argen-X (ARGX.BR), UCB SA (UCB.BR), argenx NV ADR (ARGX), as of 2026-11-19.

How does AXSM score against its peers?

Axsome Therapeutics Inc's composite reads 36/100, ranking 7 of 7 in its cohort as of 2026-11-19; the cohort's highest composite is Halozyme Therapeutics Inc at 72/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.